ABIO Annual Total Liabilities
$841.00 K
-$571.00 K-40.44%
31 December 2023
Summary:
As of January 24, 2025, ABIO annual total liabilities is $841.00 thousand, with the most recent change of -$571.00 thousand (-40.44%) on December 31, 2023. During the last 3 years, it has fallen by -$3.07 million (-78.48%).ABIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Quarterly Total Liabilities
$1.27 M
-$310.00 K-19.61%
30 June 2024
Summary:
As of January 24, 2025, ABIO quarterly total liabilities is $1.27 million, with the most recent change of -$310.00 thousand (-19.61%) on June 30, 2024. Over the past year, it has increased by +$430.00 thousand (+51.13%).ABIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.4% | +51.1% |
| 3 y3 years | -78.5% | -64.6% |
| 5 y5 years | +6.0% | -64.6% |
ABIO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -99.3% | -98.9% |
ARCA Biopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $1.27 M(-19.6%) |
| Mar 2024 | - | $1.58 M(+88.0%) |
| Dec 2023 | $841.00 K(-40.4%) | $841.00 K(-30.8%) |
| Sept 2023 | - | $1.22 M(-34.1%) |
| June 2023 | - | $1.84 M(+20.7%) |
| Mar 2023 | - | $1.53 M(+8.2%) |
| Dec 2022 | $1.41 M(-63.6%) | $1.41 M(-36.9%) |
| Sept 2022 | - | $2.24 M(-28.7%) |
| June 2022 | - | $3.14 M(+2.0%) |
| Mar 2022 | - | $3.08 M(-20.7%) |
| Dec 2021 | $3.88 M(-0.7%) | $3.88 M(+8.0%) |
| Sept 2021 | - | $3.59 M(-13.0%) |
| June 2021 | - | $4.13 M(+26.1%) |
| Mar 2021 | - | $3.27 M(-16.2%) |
| Dec 2020 | $3.91 M(+322.0%) | $3.91 M(+155.9%) |
| Sept 2020 | - | $1.53 M(+15.0%) |
| June 2020 | - | $1.33 M(+15.0%) |
| Mar 2020 | - | $1.16 M(+24.7%) |
| Dec 2019 | $926.00 K(+16.8%) | $926.00 K(-19.5%) |
| Sept 2019 | - | $1.15 M(-4.1%) |
| June 2019 | - | $1.20 M(-6.9%) |
| Mar 2019 | - | $1.29 M(+62.4%) |
| Dec 2018 | $793.00 K(-62.1%) | $793.00 K(-19.2%) |
| Sept 2018 | - | $982.00 K(-8.1%) |
| June 2018 | - | $1.07 M(-38.4%) |
| Mar 2018 | - | $1.73 M(-17.0%) |
| Dec 2017 | $2.09 M(-14.2%) | $2.09 M(-18.6%) |
| Sept 2017 | - | $2.57 M(+0.8%) |
| June 2017 | - | $2.55 M(-0.2%) |
| Mar 2017 | - | $2.55 M(+4.8%) |
| Dec 2016 | $2.44 M(+61.9%) | $2.44 M(+10.7%) |
| Sept 2016 | - | $2.20 M(+26.1%) |
| June 2016 | - | $1.74 M(-25.6%) |
| Mar 2016 | - | $2.34 M(+55.9%) |
| Dec 2015 | $1.50 M(+8.1%) | $1.50 M(+15.3%) |
| Sept 2015 | - | $1.30 M(-3.9%) |
| June 2015 | - | $1.36 M(+19.7%) |
| Mar 2015 | - | $1.13 M(-18.5%) |
| Dec 2014 | $1.39 M(-7.5%) | $1.39 M(+65.4%) |
| Sept 2014 | - | $841.00 K(-31.0%) |
| June 2014 | - | $1.22 M(+8.7%) |
| Mar 2014 | - | $1.12 M(-25.4%) |
| Dec 2013 | $1.50 M(+392.8%) | $1.50 M(+95.4%) |
| Sept 2013 | - | $769.00 K(+2.5%) |
| June 2013 | - | $750.00 K(-9.4%) |
| Mar 2013 | - | $828.00 K(+171.5%) |
| Dec 2012 | $305.00 K(-60.4%) | $305.00 K(+6.6%) |
| Sept 2012 | - | $286.00 K(-45.9%) |
| June 2012 | - | $529.00 K(-12.1%) |
| Mar 2012 | - | $602.00 K(-21.8%) |
| Dec 2011 | $770.00 K(-44.4%) | $770.00 K(+12.2%) |
| Sept 2011 | - | $686.00 K(-33.8%) |
| June 2011 | - | $1.04 M(-39.1%) |
| Mar 2011 | - | $1.70 M(+22.8%) |
| Dec 2010 | $1.39 M | $1.39 M(+34.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $1.03 M(-16.4%) |
| June 2010 | - | $1.23 M(-9.8%) |
| Mar 2010 | - | $1.37 M(-30.3%) |
| Dec 2009 | $1.96 M(-96.0%) | $1.96 M(-62.0%) |
| Sept 2009 | - | $5.16 M(-77.2%) |
| June 2009 | - | $22.56 M(-14.6%) |
| Mar 2009 | - | $26.43 M(-46.3%) |
| Dec 2008 | $49.26 M(-7.1%) | $49.26 M(+60.5%) |
| Sept 2008 | - | $30.68 M(-11.5%) |
| June 2008 | - | $34.67 M(-33.4%) |
| Mar 2008 | - | $52.06 M(-1.8%) |
| Dec 2007 | $53.02 M(-53.7%) | $53.02 M(-8.5%) |
| Sept 2007 | - | $57.98 M(-12.1%) |
| June 2007 | - | $65.97 M(-35.3%) |
| Mar 2007 | - | $102.02 M(-10.9%) |
| Dec 2006 | $114.56 M(+123.4%) | $114.56 M(+23.5%) |
| Sept 2006 | - | $92.75 M(+2.0%) |
| June 2006 | - | $90.89 M(-3.6%) |
| Mar 2006 | - | $94.24 M(+83.8%) |
| Dec 2005 | $51.28 M(+52.3%) | $51.28 M(+5.7%) |
| Sept 2005 | - | $48.51 M(+19.3%) |
| June 2005 | - | $40.68 M(+18.7%) |
| Mar 2005 | - | $34.26 M(+1.7%) |
| Dec 2004 | $33.67 M(-4.1%) | $33.67 M(-19.5%) |
| Sept 2004 | - | $41.82 M(+2.2%) |
| June 2004 | - | $40.92 M(-0.4%) |
| Mar 2004 | - | $41.08 M(+17.0%) |
| Dec 2003 | $35.11 M(+11.0%) | $35.11 M(-9.8%) |
| Sept 2003 | - | $38.94 M(+15.3%) |
| June 2003 | - | $33.77 M(-12.1%) |
| Mar 2003 | - | $38.44 M(+21.5%) |
| Dec 2002 | $31.64 M(+29.8%) | $31.64 M(+54.7%) |
| Sept 2002 | - | $20.45 M(-14.0%) |
| June 2002 | - | $23.79 M(-7.3%) |
| Mar 2002 | - | $25.67 M(+5.3%) |
| Dec 2001 | $24.37 M(+88.5%) | $24.37 M(+60.9%) |
| Sept 2001 | - | $15.14 M(+1.8%) |
| June 2001 | - | $14.88 M(+8.9%) |
| Mar 2001 | - | $13.66 M(+5.7%) |
| Dec 2000 | $12.93 M(-20.2%) | $12.93 M(-22.3%) |
| Sept 2000 | - | $16.63 M(-17.3%) |
| June 2000 | - | $20.10 M(-2.9%) |
| Mar 2000 | - | $20.70 M(+27.8%) |
| Dec 1999 | $16.20 M(+57.3%) | $16.20 M(+48.6%) |
| Sept 1999 | - | $10.90 M(+21.1%) |
| June 1999 | - | $9.00 M(-7.2%) |
| Mar 1999 | - | $9.70 M(-5.8%) |
| Dec 1998 | $10.30 M(+151.2%) | $10.30 M(+145.2%) |
| Sept 1998 | - | $4.20 M(-2.3%) |
| June 1998 | - | $4.30 M(+7.5%) |
| Mar 1998 | - | $4.00 M(-2.4%) |
| Dec 1997 | $4.10 M(+105.0%) | $4.10 M(-14.6%) |
| Sept 1997 | - | $4.80 M(+37.1%) |
| June 1997 | - | $3.50 M(+84.2%) |
| Mar 1997 | - | $1.90 M |
| Dec 1996 | $2.00 M | - |
FAQ
- What is ARCA biopharma annual total liabilities?
- What is the all time high annual total liabilities for ARCA biopharma?
- What is ARCA biopharma annual total liabilities year-on-year change?
- What is ARCA biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for ARCA biopharma?
- What is ARCA biopharma quarterly total liabilities year-on-year change?
What is ARCA biopharma annual total liabilities?
The current annual total liabilities of ABIO is $841.00 K
What is the all time high annual total liabilities for ARCA biopharma?
ARCA biopharma all-time high annual total liabilities is $114.56 M
What is ARCA biopharma annual total liabilities year-on-year change?
Over the past year, ABIO annual total liabilities has changed by -$571.00 K (-40.44%)
What is ARCA biopharma quarterly total liabilities?
The current quarterly total liabilities of ABIO is $1.27 M
What is the all time high quarterly total liabilities for ARCA biopharma?
ARCA biopharma all-time high quarterly total liabilities is $114.56 M
What is ARCA biopharma quarterly total liabilities year-on-year change?
Over the past year, ABIO quarterly total liabilities has changed by +$430.00 K (+51.13%)